This protocol is judged by an institutional evaluation board, an independent team that critiques any scientific trials involving humans. If a analyze consists of a Timetable I drug, as soon as the board approves the protocol as ethical, the scientists need to make an application for an investigational new drug (IND) variety in the FDA.copyright imp